Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies.
Paller AS, Lebwohl M, Fleischer AB Jr, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ; US/Canada Tacrolimus Ointment Study Group. Paller AS, et al. Among authors: langley rg. J Am Acad Dermatol. 2005 May;52(5):810-22. doi: 10.1016/j.jaad.2004.12.038. J Am Acad Dermatol. 2005. PMID: 15858471 Clinical Trial.
1% pimecrolimus cream for atopic dermatitis.
Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K. Eichenfield LF, et al. Among authors: langley rg. Arch Dermatol. 2003 Oct;139(10):1369-70; author reply 1370-1. doi: 10.1001/archderm.139.10.1369. Arch Dermatol. 2003. PMID: 14568846 No abstract available.
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.
Belsito DV, Fowler JF Jr, Marks JG Jr, Pariser DM, Hanifin J, Duarte IA, Pires MC, Cruz PD Jr, Langley RG, Patel P, Bush C, Thurston M, Graeber M, Cherill R; Multicenter Investigator Group. Belsito DV, et al. Among authors: langley rg. Cutis. 2004 Jan;73(1):31-8. Cutis. 2004. PMID: 14964629 Clinical Trial.
Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome.
Eichenfield LF, Lucky AW, Langley RG, Lynde C, Kaufmann R, Todd G, Lindsley L, Barbier N, Felser JM. Eichenfield LF, et al. Among authors: langley rg. Int J Dermatol. 2005 Jan;44(1):70-5. doi: 10.1111/j.1365-4632.2004.02234.x. Int J Dermatol. 2005. PMID: 15663667 Clinical Trial.
Consensus statement on the safety profile of topical calcineurin inhibitors.
Bieber T, Cork M, Ellis C, Girolomoni G, Groves R, Langley R, Luger T, Meurer M, Murrell D, Orlow S, Paller A, de Prost Y, Puig L, Ring J, Saurat JH, Schwarz T, Shear N, Stingl G, Taieb A, Thestrup-Pedersen K; Pediatric Advisory Committee of the Food and Drug Administration. Bieber T, et al. Dermatology. 2005;211(2):77-8. doi: 10.1159/000086431. Dermatology. 2005. PMID: 16088148 No abstract available.
206 results